Copernicus Therapeutics, Inc.
Categories
Gene and Cell TherapyDescription
Cleveland, OH 44106-3060
Copernicus Therapeutics, Inc. is a trial phase biopharmaceutical company utilizing newly developed nanoparticle technologies to produce safe and effective DNA drugs. Copernicus' recent Phase I/II cystic fibrosis therapeutic clinical trial results demonstrate that DNA nanoparticles efficiently transfer their DNA payload into the nucleus of differentiated airway cells, and do so without causing any significant toxicities. With additional funding, Copernicus will be able to develop products to treat diseases involving the central nervous system. Copernicus' lead product is for cystic fibrosis, a planned second therapeutic will be for treating blindness (retinitis pigmentosa) and a third product being a treatment for Parkinson's disease.
Business Overview
Directions to listing
Disclaimer
The Ohio Life Sciences Directory is provided by Ohio Life Sciences for the purpose of promoting life sciences-related organizations in Ohio. Profiles are based on publicly available and company-provided information. Ohio Life Sciences is a member supported organization, therefore members are prioritized in search results and receive special logo visibility, but non-members are included. Members may request a targeted, staff-generated offline search of the Directory. Ohio Life Sciences works to keep the Directory up to date, however, as details may change without notice, users should always refer to the listed organization directly for current information. Placement of a Directory listing does not represent an endorsement or testimony from Ohio Life Sciences as to the quality/validity of the products/services listed. Ohio Life Sciences retains exclusive management of OhioLifeSciences.org content and reserves the right to accept, reject, or remove listings on the Ohio Life Sciences website at any time. Questions? Want to update or list your organization? Please visit our contact page.